Related references
Note: Only part of the references are listed.Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
Paul D. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Targeting brain metastases with ultrasmall theranostic nanoparticles, a first-in-human trial from an MRI perspective
Camille Verry et al.
SCIENCE ADVANCES (2020)
EPR-mediated tumor targeting using ultrasmall-hybrid nanoparticles: From animal to human with theranostic AGuIX nanoparticles
Guillaume Bort et al.
THERANOSTICS (2020)
Treatment of multiple brain metastases using gadolinium nanoparticles and radiotherapy: NANO-RAD, a phase I study protocol
Camille Verry et al.
BMJ OPEN (2019)
Evaluation of a magnetic resonance guided linear accelerator for stereotactic radiosurgery treatment
Ning Wen et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Metal-based NanoEnhancers for Future Radiotherapy: Radiosensitizing and Synergistic Effects on Tumor Cells
Yan Liu et al.
THERANOSTICS (2018)
Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
Sebastian Zschaeck et al.
RADIATION ONCOLOGY (2018)
Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy
Alexandre Detappe et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
Paula Mulvenna et al.
LANCET (2016)
MRI-guided clinical 6-MV radiosensitization of glioma using a unique gadolinium-based nanoparticles injection
Camille Verry et al.
NANOMEDICINE (2016)
Gadolinium-Based Nanoparticles and Radiation Therapy for Multiple Brain Melanoma Metastases: Proof of Concept before Phase I Trial
Shady Kotb et al.
THERANOSTICS (2016)
Nanoparticles for Radiation Therapy Enhancement: the Key Parameters
Paul Retif et al.
THERANOSTICS (2015)
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
Vinai Gondi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
Stanley L. Liauw et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Toward an Image-Guided Microbeam Radiation Therapy Using Gadolinium-Based Nanoparticles
Geraldine Le Duc et al.
ACS NANO (2011)
Ultrasmall Rigid Particles as Multimodal Probes for Medical Applications
Francois Lux et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
The effect of tumor subtype on survival and the graded prognostic assessment (GPA) for patients with breast cancer and brain metastases.
P. W. Sperduto et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles
Stephen J. McMahon et al.
SCIENTIFIC REPORTS (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
MOTEXAFIN GADOLINIUM COMBINED WITH PROMPT WHOLE BRAIN RADIOTHERAPY PROLONGS TIME TO NEUROLOGIC PROGRESSION IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES: RESULTS OF A PHASE III TRIAL
Minesh P. Mehta et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study
M Klein et al.
LANCET (2002)
Share Paper
